EBSA Events
15th Annual Conference of the European Biosafety Association |
 |
| Manchester/UK |
|---|
| Workshops: 11 June 2012 Conference: 12 - 13 June 2012 |
9th EBSA 2006 Programme outline
| PRE-CONFERENCE WORKSHOPS - WEDNESDAY, 31st May 2006 | ||||
| These workshops are run concurrently on Wednesday, 31st May from 09.00 until 16.30 hrs, the day prior to the Annual Conference. They are intended as training, and offer participants the regulatory and/or scientific backgrounds, but also plenty of opportunity for practical learning through interaction with experts in the field and colleagues. | ||||
| Workshop Registration | 08.30-09.00 | |||
 |
||||
| • Workshop A: Behavioural-based safety Tim Marsh, Ryder Marsh (Safety) Limited, UK |
09.00-16.30 | |||
| The workshop is a walk-through of the various best-practice behavioural techniques that can help an organisation greatly improve its safety culture. As well as covering the concepts that underpin them, it has a particular focus on the "why do individuals do what they do" and what organisations can do to address the problems posed by human nature and the causes of human error. Case studies are used throughout the day to illustrate that all accidents could have been prevented and that management nearly always had an opportunity to prevent them. |
||||
| • Workshop B: Animals and infectious organisms Jan A.M. Langermans, Experimental Animal Services, Division Infectious Diseases, Animal Sciences group of Wageningen University and Research Centre, The Netherlands Bert Jan Haijema, Faculty of Veterinary Medicine, The Netherlands Ellen Joosten and Barry Plooyer, Intervet Nederland B.V, The Netherlands |
09.00-16.30 | |||
|
Handling animals in association with infectious agents requires meeting the regulations, codes and guidelines to address quality animal care, employee safety and environmental protection. Both small and large animals need special attention for welfare, housing, containment and waste disposal. High containment requirements, handling small and large experimental animals will be addressed in morning lectures and interactive case studies on these subjects will be held in the afternoon. |
||||
| • Workshop C: | CANCELLED | |||
|
|
||||
| • Workshop D: Designing and managing of a BSL3 laboratory Evelien Kampert, National Institute of Public Health and the Environment, The Netherlands Philippe Stroot, GlaxoSmithKline, Belgium |
09.00-16.30 | |||
| This full day course has been designed for biosafety professionals and facility managers who have at least a basic knowledge of biological safety regulations and some experience in running a BSL2 facility. It will consist of two modules, one on BSL3 laboratory design and construction, the other on laboratory operation and management. The module on design will cover the main organizational and conceptual aspects as well as some very specific, practical issues to consider when dealing with a construction or renovation project. The choice of equipment as well as commissioning and validation will be discussed. The management module will cover subjects like responsibilities, information and training, personal protection, health surveillance, work practices, waste management, cleaning and maintenance, and emergency procedures. Exchange of experiences between participants and instructors will be encouraged through a few exercises and case studies. |
||||
• Workshop E: Risk assessment Hans Bergmans, RIVM Bilthoven, The Netherlands Gary Burns, AstraZeneca, UK Kathrin Summermatter, IVI, Switzerland Helmut Bachmayer, Novartis Int., Austria |
09.00-16.30 | |||
| The workshop will start by introducing the principles and methods underlying risk assessment for activities involving hazardous biological materials and an overview about the case studies to be discussed in the afternoon. This will be followed by an interactive session involving participants, and then by a more focused consideration of risk assessment involving work with different micro-organisms and with a variety of biological materials where there is known, suspect or possible contamination with infectious agents. Using the case study approach, participants will work in smaller groups to develop and understand the process of risk assessment as it relates to biosafety. At the end of the course, participants will share their learning in a concluding plenary session. Note: This workshop is similar to the one offered in Prague (2004). EBSA has been approached by a number of colleagues asking for this topic again. |
||||
| Welcome reception at the World Forum Convention Center (WFCC) | 18.00 - 20.00 | |||
|
|
||||
CONFERENCE - THURSDAY, JUNE 1st. |
||||
PRESIDENT'S WELCOME Welcome by Mr. A.B. (Ton) Holtkamp, Director Stoffen Afvalstoffen Straling, Directoraat generaal Milieu, Ministry of VROM |
09.00 - 09.15 | |||
| SESSION 1 Vaccine development - understanding and reacting to the threat in an area of emerging disease |
09.15 - 11.00 | |||
| Chair: Frans Delemarre, Crucell, The Netherlands |
||||
| Emergency preparedness Tim Brooks, Health Protection Agency, UK |
09.15 - 09.45 | |||
| Chris Collins lecture: Vaccine development for SARS, influenza and smallpox Albert Osterhaus, Erasmus MC, The Netherlands |
09.45 - 10.30 | |||
| Facility issues for highly pathogenic avian influenza Jon Crane, CUH2A, UK Scott Stirton, SmithCarter Hemisphere, Canada |
10.30 - 11.00 | |||
| BREAK | 11.00 -11.30 | |||
| SESSION 2 Decontamination: comparing and contrasting different technologies; efficacy testing |
11.30 - 12.30 | |||
| Chair: Joke Ederveen, Progress PME, The Netherlands | ||||
| A new EU approved animal carcass decontamination and disposal technology Joseph Wilson & Sandy Sullivan, WR2 Europe, UK |
11.30 - 12.00 | |||
| Principles of virucidal testing in vitro and in vivo Jochen Steinmann, Mikrolab GmbH, Germany |
12.00 - 12.30 | |||
| LUNCH | 12.30 - 14.00 | |||
| SESSION 3 Concurrent break-out sessions |
14.00 - 15.15 | |||
|
Discussion Group 1: Transport regulations of pathogens And GMOs in Europe Discussion Group 2: European biosafety: a common approach? Discussion Group 3: Hydrogen Peroxide Vapor vs Formalin Technology Discussion Group 4: Immunization / Occupational Health |
||||
| BREAK | 15.15 - 15.45 | |||
| SESSION 4 Biosecurity |
15.45 - 16.45 | |||
| Chair: Jan-Piet Tijssen, VROM inspectorate, The Netherlands | ||||
| Outlining possible steps towards European bio-preparedness programme Lukas Holub, European Commission's Directorate-General for Justice, Freedom and Security, EC, Belgium |
15.45 - 16.15 | |||
| Cross Border Biosecurity Guy Collyer, National Counter Terrorism Security Office, UK |
16.15 - 16.45 | |||
| AGM | 17.00 - 18.00 | |||
| CONFERENCE DINNER in miniature city Madurodam | 19.30 | |||
| CONFERENCE - FRIDAY, JUNE 2nd. | ||||
| SESSION 5 Patient care and nosocomial diseases as sources of exposure (risk assessment and control of infection) |
09.00 - 10.30 | |||
| Chair: Paul Odinot, Utrecht University, The Netherlands | ||||
| Nosocomial infections: epidemiology and preventive strategies Frauke Mattner, Hannover Medical School, Germany |
09.00 - 09.30 | |||
| Healthcare is a dangerous business Peterhans van den Broek, Dutch Working Group Infection Prevention, The Netherlands |
09.30 - 10.00 | |||
| Risk assessment of bloodborne pathogens in a hospital: patients and HCWs Dimitri Sossai, Servizio Prevenzione Protezione, Italy |
10.00 - 10.30 | |||
| BREAK & POSTER SESSION | 10.30 - 11.30 | |||
| SESSION 6 Automation in biosafety |
11.30 - 12.30 | |||
| Chair: Milo Bianchetti, Clean Air Techniek BV, The Netherlands | ||||
| Containment of equipment Allan Bennett, Health Protection Agency, UK |
11.30 - 12.00 | |||
| Biosafety and cell-based high-throughput screening Gary Burns, AstraZeneca UK Ltd., UK |
12.00 - 12.30 | |||
|
LUNCH WITH COMMERCIAL SEMINAR |
12.30 - 14.00 | |||
|
Basic designs and Developments in Liquid Effluent Decontamination Systems (EDS) for BSL3 /4 Facilities |
||||
| SESSION 7 Setting directions in biosafety |
14.00 - 15.00 | |||
| Chair: Paul Jackett, Medical Research Council, UK | ||||
| Belgian Biosafety Professionals Toon de Kesel, Innogenetics, Belgium |
||||
| Co-ordination, harmonization and exchange of biosafety and biosecurity practices within a pan-European network | 14.00 - 14.15 | |||
| Kathrin Summermatter, Institute of Virology and Immunoprophylaxis, Switzerland | 14.15 - 14.30 | |||
| International biosafety laboratory standards Gary Burns, AstraZeneca, UK |
14.30 - 14:45 | |||
| Biosafety professional competence Esmeralda Prat, Bayer CropScience, Belgium |
14.45 - 15.00 | |||
| CLOSE OF CONFERENCE BY EBSA PRESIDENT 2006-2007 | 15.00 | |||